Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery

Stuart A. Grossman, Carlos G. Romo, Michelle A. Rudek, Jeffrey G. Supko, Joy Fisher, Burt Nabors, Patrick Y. Wen, David M. Peereboom, Benjamin M. Ellingson, William F. Elmquist,

Neuro-Oncology · 2020 · 36 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Author(s): Grossman, Stuart A; Romo, Carlos G; Rudek, Michelle A; Supko, Jeffrey; Fisher, Joy; Nabors, L Burt; Wen, Patrick Y; Peereboom, David M; Ellingson, Benjamin M; Elmquist, William; Barker, Fred G; Kamson, David; Sarkaria, Jann N; Timmer, William; Bindra, Ranjit S; Ye, Xiaobu

References

13